Pancreatic Cancer

• Clinical session: GI Cancers - Pancreatic cancer, Systemic treatment in adjuvant setting in colon cancer, Systemic treatment in advanced colon cancer
• Clinical session: GI Cancers - Pancreatic cancer, Systemic treatment in adjuvant setting in colon cancer, Systemic treatment in advanced colon cancer
• PIWI proteins play oncogenic functions in pancreatic cancer.
• Simultaneous unbiased and absolute quantification of a 500 protein panel in pancreatic cancer plasma using HRM mass spectrometry
• Participant Clinical Case Discussion: Metastatic Pancreatic Cancer
• Medical Treatment for Pancreatic Cancer (Localized, Locally Advanced and Metastatic)
• A goal for immunotherapy in pancreatic cancer
• Solid pseudopapillary tumor of pancreas: A case report
• Nomogram to predict cancer-specific survival in patients with pancreatic acinar cell carcinoma: A competing risk analysis
• Use of FOLFIRINOX chemotherapy in an Australasian population of pancreatic cancer
• Prognostic implication of inflammation-based scores in patients with metastatic pancreatic cancer (mPC) treated with first-line nab-paclitaxel plus...
• Runx1 enhancer element marks stem/ progenitor cells in pancreas and can be an origin of cancer
• Symptoms at diagnosis of (metastatic) pancreatic adenocarcinoma ([m]PAC) in routine practice and frequency variation across Europe
• HGCSG1403 : Phase I trial of oxaliplatin / irinotecan / S-1 (OX-IRIS) as first line chemotherapy for unresectable pancreatic cancer.
• Incidence, risk factors, and outcomes of arterial thromboembolism in patients with pancreatic cancer following palliative chemotherapy
• Liposomal irinotecan (nal-IRI) plus 5-FU/LV in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC) progressing on gemcitabine-b...
• Three-dimensional remnant pancreatic volumetry as an indicator of poor prognosis in pancreatic cancer patients after pancreatoduodenectomy
• GLRLM feature by using CT texture analysis is prognostic factor , Evaluation of pancreatic cancer heterogeneity
• Prognostic impact of progression type by RECIST criteria in patients with metastatic pancreatic cancer who received 1st line gemcitabine based chem...
• Retrospective analysis of efficacy and safety of Cell-free and Concentrated Ascites Reinfusion Therapy in pancreatic cancer patients with malignant...
• Clinical feasibility of pancreaticoduodenectomy in different ages
• Congress Highlights 2 - Gastrointestinal tumours, non-colorectal
• Relation between center volumes for pancreatic and esophageal cancer surgeries and outcome in Belgium: a plea for centralization
• Referral patterns and predictors of survival for Stage IV pancreatic ductal adenocarcinoma
• Body composition factor is independent prognosticator in advanced pancreatic cancer patients

• « Previous
• 1
• 2
• ...
• 17
• Next »